An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…


Chasing Sanofi, Pfizer tees up phase 3 trials for C. diff vaccine

Researchers publish paper on first uses of Cellectis’ CAR-T

Pfizer joins Big Pharma peers in R&D matchmaking program

Novartis, Pfizer join with Big Biopharma peers to create tech standards that streamline how HCPs access info

Pfizer licenses drug safety detection cell line from Absorption Systems

Evotec now not only a partner to Eternygen but also an investor

Draper inks Pfizer deal for preclinical work

After trial disaster, BioInvent bounces back with Pfizer deal